News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MedImmune, Inc. Announces the Discontinuation of Neutrexin (trimetrexate glucuronate) Injection


6/14/2007 4:18:59 PM

San Francisco – MedImmune announced the discontinuation of Neutrexin (trimetrexate glucuronate) Injection on March 16, 2007 in a letter to health care professionals. The letter states the drug is being discontinued in agreement with the FDA and is not due to any safety or efficacy issues with the product. To view the letter issued to healthcare professionals, please visit: http://www.fda.gov/cder/drug/shortages/NeutrexinDHCP.pdf

Read at BioSpace.com

comments powered by Disqus
MedImmune
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES